Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Vaccine, Modified Live and Killed Virus

Contents: This product contains the antigens listed above.
Gentamicin and thimerosal added as preservatives.
Indications: For subcutaneous vaccination of healthy dogs 6 weeks of age or older as an aid in the prevention of disease caused by canine distemper, infectious canine hepatitis, canine adenovirus type 2, canine coronavirus, canine parainfluenza and canine parvovirus.
Directions for Use:
General Directions: Aseptically rehydrate Duramune Max 5 with Canine Coronavirus vaccine supplied. Administer one 1 mL dose subcutaneously.
Primary Vaccination: A recommended vaccination schedule should start at or about 6 weeks of age. The presence of maternal antibody is known to interfere with the development of active immunity. Puppies should be revaccinated every 2 to 3 weeks until 12 weeks of age.All dogs over 12 weeks of age should initially receive one dose of Duramune Max 5-CvK and a second dose 2 to 3 weeks later.
Annual Vaccination: Annual revaccination with one dose is recommended.
InfoVax-ID System: The InfoVax-ID System provides a simple and effective method of recording pertinent information on the vaccines administered to animals in a veterinary practice. For vaccines requiring reconstitution, remove label from both vials and affix both labels to the animal's medical chart.
Precaution(s): Store in the dark at 2° to 7°C (35° to 45°F). Avoid freezing. Shake well. Burn container and all unused contents.
Caution(s): In the absence of a veterinarian-client-patient relationship, Federal law prohibits the relabeling, repackaging, resale, or redistribution of the individual contents of this package. (9CFRPart 112.6)
In case of anaphylactoid reaction, administer epinephrine.
Presentation: 25 doses (25 x 1 mL vials of vaccine plus 25 x 1 mL vials of diluent), featuring the InfoVax-ID System.